Quick Answer
Arcadia Biosciences, Inc. reported R&D Expense of $9.0 thousand for fiscal year 2025.
Arcadia Biosciences, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $9.0K | -83.0% |
| 2024 | $53.0K | -17.2% |
| 2023 | $64.0K | -95.8% |
| 2022 | $1.51M | -61.2% |
| 2021 | $3.89M | -51.1% |
| 2020 | $7.96M | +12.1% |
| 2019 | $7.10M | +17.0% |
| 2018 | $6.07M | -18.1% |
| 2017 | $7.41M | -14.5% |
| 2016 | $8.66M | -3.4% |
| 2015 | $8.97M | -10.4% |
| 2014 | $10.01M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.00 | -100.0% | -100.0% |
| June 30, 2025 | $9.0K | -10.0% | — |
| March 31, 2025 | $0.00 | -100.0% | -100.0% |
| September 30, 2024 | $24.0K | +60.0% | +140.0% |
| June 30, 2024 | $10.0K | -63.0% | +66.7% |
| March 31, 2024 | $6.0K | -98.3% | -60.0% |
| September 30, 2023 | $15.0K | -94.1% | -44.4% |
| June 30, 2023 | $27.0K | -92.5% | -92.5% |
- Arcadia Biosciences, Inc. showed a decrease of -83.0% in R&D Expense compared to the prior fiscal year.
- Over the 2014–2025 period, Arcadia Biosciences, Inc.’s r&d expense has declined by 99.9% (from $10.01 million to $9.0 thousand).
- The most recent figure is from Arcadia Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: